medigraphic.com

2017, Número 1

<< Anterior

Vet Mex 2017; 4 (1)


Effects of glycyrrhizic acid (Viusid-Vet® powder) on the reduction of influenza virus spread and on production parameters in pigs

Ocampo L, Tapia, G, Gutiérrez L, Sumano H

Idioma: Español/Inglés
Referencias bibliográficas: 41
Paginas: 1-13
Archivo PDF: 720.38 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Zhang H, Li X, Ma R, Li X, Zhou Y, Dong H, et al. Airborne spread and infection of a novel swine-origin influenza A (H1N1) virus. Virol J. 2013 Jun 22;10:204.

  2. Morris K. Implications of narcolepsy link with swine-influenza vaccine. Lancet Infect Dis. 2013;13:396–7.

  3. Hall JS, Teslaa JL, Nashold SW, Halpin RA, Stockwell T, Wentworth DE, et al. Evolution of a reassortant North American gull influenza virus lineage: drift, shift and stability. Virol J. 2013 Jun 6;10:179.

  4. Olsen CW, Brown IH, Easterday BC, Van Reeth K. Swine Influenza. In: Straw BE, Zimmerman JJ, Taylor DJ, D’Allaire S, editors. Diseases of Swine. Ames, Iowa State University Press; 2006. p. 469–482.

  5. Van Reeth K. Avian and swine influenza viruses: our current understanding of the zoonotic risk. Vet Res. 2007;38:243–260.

  6. Francois R. Active plant extracts show promise in poultry production. Poult Int. 2006;28–31.

  7. Franki ˇ c T, Salobir J, Rezar V, Volj ˇ c M. Use of herbs and spices and their extracts in animal nutrition. Acta Agric Slov. 2009;94:95–102.

  8. Baltina LA, Zarubaev VV, Orshanskaya IA, Fairushina AI, Kiselev OI, Yunusov MS. Glycyrrhicic acid derivatives as influenza A/H1N1 virus inhibitors. Bioorg Med Chem Lett. 2015;25:1742–6.

  9. Hirabayashi K, Iwata S, Matsumoto H, Mori T, Shibata S, Baba M, et al. Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro. Chem Pharm Bull (Tokyo). 1991 Jan;39(1):112–5.

  10. Lalita B. In vitro studies on the effect of glycyrrhizin from Indian Glycyrrhiza glabra Linn on some RNA and DNA viruses. Indian J Pharmacol. 1994 Jan 7;26(3):194.

  11. Lin JC. Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro. Antiviral Res. 2003 Jun;59(1):41–7.

  12. Hoever G, Baltina L, Michaelis M, Kondratenko R, Baltina L, Tolstikov GA, et al. Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. J Med Chem. 2005 Feb 24;48(4):1256–9.

  13. Lee C-H, Park S-W, Kim YS, Kang SS, Kim JA, Lee SH, et al. Protective mechanism of glycyrrhizin on acute liver injury induced by carbon tetrachloride in mice. Biol Pharm Bull. 2007 Oct;30(10):1898–904.

  14. Pompei R, Laconi S, Ingianni A. Antiviral properties of glycyrrhizic acid and its semisynthetic derivatives. Mini Rev Med Chem. 2009 Jul;9(8):996–1001.

  15. Chavali SR, Francis T, Campbell JB. An in vitro study of immunomodulatory effects of some saponins. Int J Immunopharmacol. 1987;9(6):675–83.

  16. Ohtsuki K, Iahida N. Inhibitory effect of glycyrrhizin on polypeptide phosphorylation by polypeptide-dependent protein kinase (kinase P) in vitro. Biochem Biophys Res Commun. 1988 Dec 15;157(2):597–604.

  17. Lo HH, Yen YS, Hsieh SE, Chung JG. Glycyrrhizic acid inhibits arylamine N-acetyltransferase activity in Klebsiella pneumoniae in vitro. J Appl Toxicol JAT. 1997 Dec;17(6):385–90.

  18. Tanaka Y, Kikuzaki H, Fukuda S, Nakatani N. Antibacterial compounds of licorice against upper airway respiratory tract pathogens. J Nutr Sci Vitaminol (Tokyo). 2001 Jun;47(3):270–3.

  19. Krausse R, Bielenberg J, Blaschek W, Ullmann U. In vitro anti-Helicobacter pylori activity of Extractum liquiritiae, glycyrrhizin and its metabolites. J Antimicrob Chemother. 2004 Jul;54(1):243–6.

  20. Ocampo CL, Gómez-Verduzco G, Tapia-Perez G, Gutierrez OL, Sumano LH. Effects of glycyrrhizic acid on productive and immunological variables in broilers. Braz J Poult Sci. 2016;18(In press).

  21. Castanon JIR. History of the use of antibiotic as growth promoters in European poultry feeds. Poult Sci. 2007 Nov;86(11):2466–71.

  22. Ocampo L, Chavez B, Tapia G, Ibarra C, Sumano H. Efficacy of a pharmaceutical preparation based on glycyrrhizic acid in a challenge study of white spot syndrome in white shrimp (Litopenaeus vannamei). Aquaculture. 2014 May 20;428–429:280–3.

  23. Buchner A, Erdfelder E, Faul F. How to Use G*Power 1997 [Internet]. 2008 [cited 2016 Feb 28]. Available from: at http://www.psycho.uni.duesseldorf.do/ aap/projects/gppwer/how_to_use_gpower.html

  24. OIE 2017. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2016 [Internet]. OIE-World Organization for Animal Health. [cited 2017 Mar 3]. Available from: http://www.oie.int/en/international-standard-setting/ terrestrial-manual/access-online/

  25. McCulloch CE, Searle SR. One-Way Classifications. In: Generalized, Linear, and Mixed Models [Internet]. John Wiley & Sons, Inc.; 2000 [cited 2017 Mar 3]. p. 28– 70. Available from: http://onlinelibrary.wiley.com/doi/10.1002/0471722073. ch2/summary

  26. Nowakowska Z. A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem. 2007 Feb;42(2):125–37.

  27. Racková L, Jancinová V, Petríková M, Drábiková K, Nosál R, Stefek M, et al. Mechanism of anti-inflammatory action of liquorice extract and glycyrrhizin. Nat Prod Res. 2007 Dec;21(14):1234–41.

  28. Utsunomiya T, Kobayashi M, Pollard RB, Suzuki F. Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus. Antimicrob Agents Chemother. 1997 Mar;41(3):551–6.

  29. Vega DG, Morales IC, López MAV, González AM. Perfil inmunológico de los cerdos durante las primeras diez semanas de edad. Vet México. 1993;24(3):217–21.

  30. Loving CL, Lager KM, Vincent AL, Brockmeier SL, Gauger PC, Anderson TK, et al. Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v. J Virol. 2013 Sep;87(17):9895–903.

  31. Brenes A, Roura E. Essential oils in poultry nutrition: Main effects and modes of action. Anim Feed Sci Technol. 2010 Jun 2;158(1–2):1–14.

  32. Vaya J, Belinky PA, Aviram M. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radic Biol Med. 1997;23(2):302–13.

  33. Kao T-C, Shyu M-H, Yen G-C. Glycyrrhizic acid and 18beta-glycyrrhetinic acid inhibit inflammation via PI3K/Akt/GSK3beta signaling and glucocorticoid receptor activation. J Agric Food Chem. 2010 Aug 11;58(15):8623–9.

  34. Armanini D, Karbowiak I, Funder JW. Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors. Clin Endocrinol (Oxf). 1983 Nov;19(5):609–12.

  35. Okimasu E, Moromizato Y, Watanabe S, Sasaki J, Shiraishi N, Morimoto YM, et al. Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug. Acta Med Okayama. 1983 Oct;37(5):385–91.

  36. Ohuchi K, Kamada Y, Levine L, Tsurufuji S. Glycyrrhizin inhibits prostaglandin E2 production by activated peritoneal macrophages from rats. Prostaglandins Med. 1981 Nov;7(5):457–63.

  37. Brown IH. The epidemiology and evolution of influenza viruses in pigs. Vet Microbiol. 2000 May 22;74(1–2):29–46.

  38. Thacker E, Janke B. Swine influenza virus: zoonotic potential and vaccination strategies for the control of avian and swine influenzas. J Infect Dis. 2008 Feb 15;197 Suppl 1:S19-24.

  39. Van Reeth K, Labarque G, De Clercq S, Pensaert M. Efficacy of vaccination of pigs with different H1N1 swine influenza viruses using a recent challenge strain and different parameters of protection. Vaccine. 2001 Aug 14;19(31):4479–86.

  40. Vincent AL, Ma W, Lager KM, Janke BH, Richt JA. Swine influenza viruses a North American perspective. Adv Virus Res. 2008;72:127–54.

  41. Størmer FC, Reistad R, Alexander J. Glycyrrhizic acid in liquorice–evaluation of health hazard. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc. 1993 Apr;31(4):303–12.




2020     |     www.medigraphic.com